Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1983;2(7):1017–1022. doi: 10.1002/j.1460-2075.1983.tb01539.x

Anti-cell surface monoclonal antibodies which antagonize the action of VIP in a human adenocarcinoma cell line (HT 29 cells).

J Pichon, M Hirn, J M Muller, P Mangeat, J Marvaldi
PMCID: PMC555228  PMID: 6313348

Abstract

Hybridoma cells have been obtained by fusing RCY 3 Ag 1-2-3 rat myeloma cells with spleen cells from a rat hyperimmunized with human adenocarcinoma cells (HT 29 cell line) grown in serum-free medium. Immunoglobulins secreted by hybridomas were screened for: (i) specific binding to HT 29 cells; (ii) their ability to inhibit the binding of [125I]-vasoactive intestinal peptide (VIP) to HT 29 cells; (iii) their capacity to modulate the cAMP production induced by VIP. The monoclonal antibodies we have obtained from clones 109-10-16 and 109-10-19 compete for the binding of radiolabelled VIP to HT 29 cells and partially inhibit the production of cAMP induced by VIP while they are ineffective in reducing the intracellular level of cAMP attained after stimulation of HT 29 cells by isoproterenol. We never found antibodies which increase the cAMP level in HT 29 cells. The binding of the purified monoclonal antibody 109-10-16 Ig gamma 2c to HT 29 cells was visualized by indirect immunofluorescence and was not present at the surface of all cells. These observations strongly support the hypothesis that the monoclonal antibodies we have characterized interact with an antigenic determinant which belongs to the VIP receptor or at least to a cell surface component closely associated with the receptor.

Full text

PDF
1017

Images in this article

1019Fig. 3.
on p.1019
1020Fig. 4.
on p.1020

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cailla H. L., Racine-Weisbuch M. S., Delaage M. A. Adenosine 3',5' cyclic monophosphate assay at 10-15 mole level. Anal Biochem. 1973 Dec;56(2):394–407. doi: 10.1016/0003-2697(73)90205-4. [DOI] [PubMed] [Google Scholar]
  2. Costa M., Furness J. B., Buffa R., Said S. I. Distribution of enteric nerve cell bodies and axons showing immunoreactivity for vasoactive intestinal polypeptide in the guinea-pig intestine. Neuroscience. 1980;5(3):587–596. doi: 10.1016/0306-4522(80)90056-1. [DOI] [PubMed] [Google Scholar]
  3. Flier J. S., Kahn C. R., Roth J., Bar R. S. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science. 1975 Oct 3;190(4209):63–65. doi: 10.1126/science.170678. [DOI] [PubMed] [Google Scholar]
  4. Galfrè G., Milstein C., Wright B. Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature. 1979 Jan 11;277(5692):131–133. doi: 10.1038/277131a0. [DOI] [PubMed] [Google Scholar]
  5. Goding J. W. Antibody production by hybridomas. J Immunol Methods. 1980;39(4):285–308. doi: 10.1016/0022-1759(80)90230-6. [DOI] [PubMed] [Google Scholar]
  6. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  7. Haigler H. T., Carpenter G. Production and characterization of antibody blocking epidermal growth factor:receptor interactions. Biochim Biophys Acta. 1980 May 23;598(2):314–325. doi: 10.1016/0005-2736(80)90009-7. [DOI] [PubMed] [Google Scholar]
  8. Hirn M., Demierre M., Goridis C. A solid-phase radioimmunoassay for detecting antibodies to brain cell surface antigens. Brain Res Bull. 1981 Oct;7(4):441–444. doi: 10.1016/0361-9230(81)90044-7. [DOI] [PubMed] [Google Scholar]
  9. Jacobs S., Chang K. J., Cuatrecasas P. Antibodies to purified insulin receptor have insulin-like activity. Science. 1978 Jun 16;200(4347):1283–1284. doi: 10.1126/science.663609. [DOI] [PubMed] [Google Scholar]
  10. Köhler G., Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol. 1976 Jul;6(7):511–519. doi: 10.1002/eji.1830060713. [DOI] [PubMed] [Google Scholar]
  11. Laburthe M., Rousset M., Boissard C., Chevalier G., Zweibaum A., Rosselin G. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2772–2775. doi: 10.1073/pnas.75.6.2772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976 Nov;26(11):1054–1059. doi: 10.1212/wnl.26.11.1054. [DOI] [PubMed] [Google Scholar]
  14. Mehdi S. Q., Nussey S. S. A radio-ligand receptor assay for the long-acting thyroid stimulator. Inhibition by the long-acting thyroid stimulator of the binding of radioiodinated thyroid-stimulating hormone to human thyroid membranes. Biochem J. 1975 Jan;145(1):105–111. doi: 10.1042/bj1450105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Milstein C., Galfre G., Secher D. S., Springer T. Monoclonal antibodies and cell surface antigens. Cell Biol Int Rep. 1979 Jan;3(1):1–16. doi: 10.1016/0309-1651(79)90063-8. [DOI] [PubMed] [Google Scholar]
  16. Murakami H., Masui H., Sato G. H., Sueoka N., Chow T. P., Kano-Sueoka T. Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1158–1162. doi: 10.1073/pnas.79.4.1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rousset M., Laburthe M., Chevalier G., Boissard C., Rosselin G., Zweibaum A. Vasoactive intestinal peptide (VIP) control of glycogenolysis in the human colon carcinoma cell line HT-29 in culture. FEBS Lett. 1981 Apr 6;126(1):38–40. doi: 10.1016/0014-5793(81)81027-7. [DOI] [PubMed] [Google Scholar]
  18. Said S. I., Mutt V. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem. 1972 Jul 13;28(2):199–204. doi: 10.1111/j.1432-1033.1972.tb01903.x. [DOI] [PubMed] [Google Scholar]
  19. Said S. I., Mutt V. Relationship of spasmogenic and smooth muscle relaxant peptides from normal lung to other vasoactive compounds. Nature. 1977 Jan 6;265(5589):84–86. doi: 10.1038/265084a0. [DOI] [PubMed] [Google Scholar]
  20. Schreiber A. B., Lax I., Yarden Y., Eshhar Z., Schlessinger J. Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7535–7539. doi: 10.1073/pnas.78.12.7535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sims K. B., Hoffman D. L., Said S. I., Zimmerman E. A. Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Brain Res. 1980 Mar 17;186(1):165–183. doi: 10.1016/0006-8993(80)90263-2. [DOI] [PubMed] [Google Scholar]
  22. Tatemoto K., Mutt V. Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6603–6607. doi: 10.1073/pnas.78.11.6603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Venter J. C., Fraser C. M., Harrison L. C. Autoantibodies to beta 2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma. Science. 1980 Mar 21;207(4437):1361–1363. doi: 10.1126/science.6153472. [DOI] [PubMed] [Google Scholar]
  24. Wrenn S., Haber E. An antibody specific for the propranolol binding site of cardiac muscle. J Biol Chem. 1979 Jul 25;254(14):6577–6582. [PubMed] [Google Scholar]
  25. Yavin E., Yavin Z., Schneider M. D., Kohn L. D. Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease. Proc Natl Acad Sci U S A. 1981 May;78(5):3180–3184. doi: 10.1073/pnas.78.5.3180. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES